Obesity and inflammation: the linking mechanism and the complications
- PMID: 28721154
- PMCID: PMC5507106
- DOI: 10.5114/aoms.2016.58928
Obesity and inflammation: the linking mechanism and the complications
Abstract
Obesity is the accumulation of abnormal or excessive fat that may interfere with the maintenance of an optimal state of health. The excess of macronutrients in the adipose tissues stimulates them to release inflammatory mediators such as tumor necrosis factor α and interleukin 6, and reduces production of adiponectin, predisposing to a pro-inflammatory state and oxidative stress. The increased level of interleukin 6 stimulates the liver to synthesize and secrete C-reactive protein. As a risk factor, inflammation is an imbedded mechanism of developed cardiovascular diseases including coagulation, atherosclerosis, metabolic syndrome, insulin resistance, and diabetes mellitus. It is also associated with development of non-cardiovascular diseases such as psoriasis, depression, cancer, and renal diseases. On the other hand, a reduced level of adiponectin, a significant predictor of cardiovascular mortality, is associated with impaired fasting glucose, leading to type-2 diabetes development, metabolic abnormalities, coronary artery calcification, and stroke. Finally, managing obesity can help reduce the risks of cardiovascular diseases and poor outcome via inhibiting inflammatory mechanisms.
Keywords: C reactive protein; adiponectin; inflammation; interleukin 6; linking mechanism; obesity.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5507106/bin/AMS-13-27238-g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5507106/bin/AMS-13-27238-g002.gif)
Similar articles
-
Recent advances in the relationship between obesity, inflammation, and insulin resistance.Eur Cytokine Netw. 2006 Mar;17(1):4-12. Eur Cytokine Netw. 2006. PMID: 16613757 Review.
-
Obesity, adiponectin and vascular inflammatory disease.Curr Opin Lipidol. 2003 Dec;14(6):561-6. doi: 10.1097/00041433-200312000-00003. Curr Opin Lipidol. 2003. PMID: 14624132 Review.
-
The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.Med Hypotheses. 2006;67(4):879-91. doi: 10.1016/j.mehy.2006.04.008. Epub 2006 Jun 15. Med Hypotheses. 2006. PMID: 16781084
-
Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.Dan Med J. 2014 Jul;61(7):B4890. Dan Med J. 2014. PMID: 25123125 Review.
-
Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying actions of the thiazolidinediones.Biochimie. 2003 Dec;85(12):1219-30. doi: 10.1016/j.biochi.2003.10.010. Biochimie. 2003. PMID: 14739074 Review.
Cited by
-
The impact of duration and severity of obesity exposure on cardiometabolic health.Obes Surg. 2024 Jul;34(7):2587-2595. doi: 10.1007/s11695-024-07331-0. Epub 2024 Jun 4. Obes Surg. 2024. PMID: 38833133 Free PMC article.
-
Interactions and Trends of Interleukins, PAI-1, CRP, and TNF-α in Inflammatory Responses during the Perioperative Period of Joint Arthroplasty: Implications for Pain Management-A Narrative Review.J Pers Med. 2024 May 17;14(5):537. doi: 10.3390/jpm14050537. J Pers Med. 2024. PMID: 38793119 Free PMC article. Review.
-
Predictors, Protective Factors, and Adverse Outcomes of Joint Pain among Malaysian Community-Dwelling Older Adults: Findings from the LRGS-TUA Longitudinal Study.J Clin Med. 2024 May 12;13(10):2854. doi: 10.3390/jcm13102854. J Clin Med. 2024. PMID: 38792397 Free PMC article.
-
The Lipid Accumulation Product Index (LAP) and the Cardiometabolic Index (CMI) Are Useful for Predicting the Presence and Severity of Metabolic Syndrome in Adult Patients with Obesity.J Clin Med. 2024 May 11;13(10):2843. doi: 10.3390/jcm13102843. J Clin Med. 2024. PMID: 38792386 Free PMC article.
-
Exploring the Complex Interplay of Obesity, Allergic Diseases, and Sleep-Disordered Breathing in Children.Children (Basel). 2024 May 15;11(5):595. doi: 10.3390/children11050595. Children (Basel). 2024. PMID: 38790590 Free PMC article. Review.
References
-
- Romano M. Inflammation resolution: does the bone marrow have a say? Am J Hematol. 2008;83:435–6. - PubMed
-
- Feuerstein GZ, Libby P, Mann DL. Inflammation – a new frontier in cardiac disease and therapeutics. In: Feuerstein GZ, Libby P, Mann DL, editors. Inflammation and cardiac diseases. Birkhäuser Basel; 2003. pp. 1–5.
-
- Seki H, Tani Y, Arita M. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. Prostaglandins Other Lipid Mediat. 2009;89:126–30. - PubMed
-
- Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 2004;29:439–43. - PubMed
-
- Lafontan M. Fat cells: afferent and efferent messages define new approaches to treat obesity. Annu Rev Pharmacol Toxicol. 2004;45:119–46. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials